Not applicableStudy completedNCT02534311
What this trial is testing
A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28)
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 60